1. Home
  2. ITRM vs WAL Comparison

ITRM vs WAL Comparison

Compare ITRM & WAL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Iterum Therapeutics plc

ITRM

Iterum Therapeutics plc

HOLD

Current Price

$0.17

Market Cap

24.3M

Sector

Health Care

ML Signal

HOLD

Logo Western Alliance Bancorporation (DE)

WAL

Western Alliance Bancorporation (DE)

HOLD

Current Price

$80.85

Market Cap

9.6B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
ITRM
WAL
Founded
2015
1994
Country
Ireland
United States
Employees
N/A
3524
Industry
Biotechnology: Pharmaceutical Preparations
Major Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
24.3M
9.6B
IPO Year
2018
N/A

Fundamental Metrics

Financial Performance
Metric
ITRM
WAL
Price
$0.17
$80.85
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
15
Target Price
$9.00
$101.40
AVG Volume (30 Days)
1.0M
1.4M
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
2.06%
EPS Growth
57.43
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$20.16
Revenue Next Year
$947.65
$8.63
P/E Ratio
N/A
$10.88
Revenue Growth
N/A
N/A
52 Week Low
$0.14
$57.05
52 Week High
$1.49
$97.23

Technical Indicators

Market Signals
Indicator
ITRM
WAL
Relative Strength Index (RSI) 34.76 36.61
Support Level N/A $70.53
Resistance Level $0.39 $82.37
Average True Range (ATR) 0.04 3.57
MACD -0.01 -1.47
Stochastic Oscillator 15.94 17.23

Price Performance

Historical Comparison
ITRM
WAL

About ITRM Iterum Therapeutics plc

Iterum Therapeutics PLC is a pharmaceutical company dedicated to maximizing the commercial potential of Orlynvah, an oral-branded penem available in the United States and potentially the first and only oral and intravenous (IV) branded penem available globally. Its product Orlynvah has the potential to be a treatment for complicated urinary tract infections caused by the designated microorganisms, without the presence of known toxicities of some other antibiotics. The company operates in a single business segment, which is the development and commercialization of treatments for drug-resistant bacterial infections.

About WAL Western Alliance Bancorporation (DE)

Western Alliance Bancorp provides a full spectrum of customized loan, deposit, and treasury management capabilities, including funds transfer and other digital payment offerings. The company's reportable segments are Commercial segment includes provides commercial banking and treasury management products and services to small and middle-market businesses, specialized banking services to sophisticated commercial institutions and investors within niche industries, as well as financial services to the real estate industry. Consumer Related segment offers both commercial banking services to enterprises in consumer-related sectors and consumer banking services, such as residential mortgage banking and Corporate & Other.

Share on Social Networks: